In mesenchymal-like cancer cells (231), site 1 and site 2 are, respectively, occupied by Complex 1 and Complex 2, leading to alterations of epigenetic markers on distal and proximal region of the E-cadherin promoter and the silencing of E-cadherin (Fig. 7). The gene discussed is CDH1; the disease is cancer.